BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7021104)

  • 1. Field test results using the BioPEPR cervical smear prescreening system.
    Zahniser DJ; Oud PS; Raaijmakers MC; Vooys GP; Van de Walle RT
    Cytometry; 1980 Nov; 1(3):200-3. PubMed ID: 7021104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BioPEPR: a system for the automatic prescreening of cervical smears.
    Zahniser DJ; Oud PS; Raaijmakers MC; Vooys GP; Van de Walle RT
    J Histochem Cytochem; 1979 Jan; 27(1):635-41. PubMed ID: 86581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thionine-Feulgen-Congo red staining of cervical smears for the BioPEPR image-analysis system.
    Oud PS; Zahniser DJ; Raaijmakers MC; Vooijs PG; Van de Walle RT
    Anal Quant Cytol; 1981 Dec; 3(4):289-94. PubMed ID: 6174058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LEYTAS analysis of cytological specimens: the results of thousand cervical smears.
    Goyarts-Veldstra L; van Driel-Kulker AM; Ploem-Zaaijer JJ; Meyer F; Ploem JS
    Microsc Acta Suppl; 1983; 6():147-60. PubMed ID: 6578401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidimensional slit-scan prescreening system: preliminary results of a single blind clinical study.
    Wheeless LL; Patten SF; Berkan TK; Brooks CL; Gorman KM; Lesh SR; Lopez PA; Wood JC
    Cytometry; 1984 Jan; 5(1):1-8. PubMed ID: 6697819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic value of computer-assisted primary cervical smear screening: a longitudinal cohort study.
    Doornewaard H; van der Schouw YT; van der Graaf Y; Bos AB; Habbema JD; van den Tweel JG
    Mod Pathol; 1999 Nov; 12(11):995-1000. PubMed ID: 10574595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thionine-Feulgen Congo Red -- a new staining technique for automated cytology.
    Oud PS; Zahniser DJ; Vooijs GP; Raaymakers MC; van de Walle RT
    Acta Histochem Suppl; 1981; 24():199-206. PubMed ID: 6785826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of cotton-tipped applicators for obtaining cells from the uterine cervix for Papanicolaou smears.
    Shen JT; Nalick RH; Schlaerth JB; Morrow CP
    Acta Cytol; 1984; 28(5):541-5. PubMed ID: 6592916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Papanicolaou staining and Feulgen staining for automated prescreening.
    Soost HJ; Brem W; Höbel W; Otto K; Schwarz G
    Anal Quant Cytol; 1983 Mar; 5(1):61-6. PubMed ID: 6189437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Follow up after an abnormal pap smear: time interval acceptable, nature of follow up leaves room for improvement].
    Geertsen M; Bais AG; Beerman H; Helmerhorst TJ
    Ned Tijdschr Geneeskd; 2003 Dec; 147(49):2430-4. PubMed ID: 14694554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. False positive cervical smears: a cytometric and histological study.
    Nenning H; Horn LC; Kühndel K; Bilek K
    Anal Cell Pathol; 1995 Jul; 9(1):61-8. PubMed ID: 7577756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetic acid visualization of the cervix to detect cervical dysplasia.
    Van Le L; Broekhuizen FF; Janzer-Steele R; Behar M; Samter T
    Obstet Gynecol; 1993 Feb; 81(2):293-5. PubMed ID: 8423967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual inspection of the uterine cervix after the application of acetic acid in the detection of cervical carcinoma and its precursors.
    Sankaranarayanan R; Wesley R; Somanathan T; Dhakad N; Shyamalakumary B; Amma NS; Parkin DM; Nair MK
    Cancer; 1998 Nov; 83(10):2150-6. PubMed ID: 9827719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trials with the cerviscan experimental prescreening device on polylysine-prepared slides.
    Tucker JH; Husain OA
    Anal Quant Cytol; 1981 Jun; 3(2):117-20. PubMed ID: 7020514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Two cytological methods for screening for cervical cancer].
    Kirschner B; Simonsen K; Junge J
    Ugeskr Laeger; 2008 May; 170(22):1933-7. PubMed ID: 18513478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M; Hoque E; Kader SB
    East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
    Liao SY; Stanbridge EJ
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of women with abnormal cervical cytology: treatment patterns and associated costs in England and Wales.
    Martin-Hirsch P; Rash B; Martin A; Standaert B
    BJOG; 2007 Apr; 114(4):408-15. PubMed ID: 17378815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A more accurate measure of the false-negative rate of Papanicolaou smear screening is obtained by determining the false-negative rate of the rescreening process.
    Renshaw AA; DiNisco SA; Minter LJ; Cibas ES
    Cancer; 1997 Oct; 81(5):272-6. PubMed ID: 9349513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upgrading unsatisfactory cervical smears with the MiB-1 method.
    Boon ME; Kleinschmidt-Guy ED; Wijsman-Grootendorst A; Hoogeveen MM
    Diagn Cytopathol; 1996 Nov; 15(4):270-6. PubMed ID: 8982579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.